Skip to main content
Retour
MASI logo

Masimo Corporation

Qualité des données : 100%
Suracheté
MASI
NASDAQ Healthcare Medical - Instruments & Supplies
177,11 €
▲ 0,22 € (0,12%)
Cap. Boursière : 9,51B
Fourchette du Jour
176,71 € 177,51 €
Fourchette 52 Semaines
125,94 € 178,87 €
Volume
1 001 939
Moyenne 50J / 200J
155,89 € / 150,88 €
Clôture Précédente
176,89 €

Quick Summary

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (633 pairs)

Métrique Action Médiane du Secteur
P/E -62,8 0,2
P/B 13,2 2,8
ROE % -17,1 3,7
Net Margin % -9,9 3,9
Rev Growth 5Y % 5,4 9,7
D/E 0,8 0,2

Objectif de Cours des Analystes

Hold
187,50 € +5.9%
Low: 180,00 € High: 200,00 €
P/E Prévisionnel
32,39
BPA Prévisionnel
5,50 €
Croissance BPA (est.)
+0,0%
CA Est.
1,52B

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2030 7,43 €
7,37 € – 7,49 €
1,97B 1
FY2029 7,43 €
7,37 € – 7,49 €
1,89B 1
FY2028 6,66 €
6,37 € – 7,18 €
1,75B 6

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-26 1,52 € 1,80 € +18,4%
2025-11-04 1,19 € 1,32 € +10,9%
2025-08-05 1,23 € 1,33 € +8,1%
2025-05-06 1,24 € 1,36 € +9,7%
2025-02-25 1,42 € 1,80 € +26,8%
2024-11-05 0,84 € 0,98 € +17,1%
2024-08-06 0,77 € 0,86 € +11,7%
2024-05-07 0,71 € 0,77 € +8,5%

Dividend History

Yield

0,00%

Payout Ratio

0,00%

Growth (3Y)

N/A

Growth (5Y)

N/A

Ex-Date Payment Date Amount Yield
Nov 23, 2012 Dec 11, 2012 1,00 € 4,81%
Dec 03, 2010 Dec 21, 2010 0,75 € 8,60%
Mar 09, 2010 Mar 31, 2010 2,00 € 7,45%

Points Clés

Revenue grew 5,36% annually over 5 years — modest growth
Generating 197,80M in free cash flow
PEG of 0,89 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 32,46%
Capital efficient — spends only 1,27% of revenue on capex
ROIC of 18,32% — excellent capital efficiency

Croissance

Revenue Growth (5Y)
5,36%
Revenue (1Y)-27,10%
Earnings (1Y)N/A
FCF Growth (3Y)455,93%

Qualité

Return on Equity
-17,09%
ROIC18,32%
Net Margin-9,92%
Op. Margin20,49%

Sécurité

Debt / Equity
0,78
Current Ratio2,49
Interest Coverage9,42

Valorisation

P/E Ratio
-62,79
Forward P/E32,39
P/B Ratio13,19
EV/EBITDA31,71
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -27,10% Revenue Growth (3Y) -13,66%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 5,36% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,53B Net Income (TTM) -151,50M
ROE -17,09% ROA -8,92%
Gross Margin 61,90% Operating Margin 20,49%
Net Margin -9,92% Free Cash Flow (TTM) 197,80M
ROIC 18,32% FCF Growth (3Y) 455,93%
Safety
Debt / Equity 0,78 Current Ratio 2,49
Interest Coverage 9,42
Dividends
Dividend Yield 0,00% Payout Ratio 0,00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -62,79 Forward P/E 32,39
P/B Ratio 13,19 P/S Ratio 6,23
PEG Ratio 0,89 Forward PEG N/A
EV/EBITDA 31,71 Fwd EV/EBITDA 47,23
Forward P/S 6,25 Fwd Earnings Yield 3,09%
FCF Yield 2,08%
Market Cap 9,51B Enterprise Value 9,92B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,53B 2,09B 2,05B 2,04B 1,24B
Net Income -151,50M -304,90M 81,50M 143,50M 229,60M
EPS (Diluted) -2,80 -5,72 1,51 2,60 3,98
Gross Profit 945,20M 1,00B 1,00B 1,06B 808,40M
Operating Income 312,80M -266,70M 136,50M 210,00M 275,80M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,70B 2,63B 3,04B 3,21B 1,89B
Total Liabilities 977,70M 1,57B 1,68B 1,87B 336,80M
Shareholders' Equity 721,20M 1,05B 1,36B 1,34B 1,55B
Total Debt 559,30M 846,10M 970,00M 1,03B 32,70M
Cash & Equivalents 152,30M 177,60M 163,00M 202,90M 745,30M
Current Assets 926,00M 1,23B 1,23B 1,31B 1,24B
Current Liabilities 371,60M 617,70M 563,80M 630,00M 267,70M